David Johnson, M.B.A.

David Johnson, M.B.A.

DirectoratVera Therapeutics· In proxies 2023–2025

Pay in FY2025Vera Therapeutics stock +19.7% the same year

David Johnson, M.B.A. was paid $2.7M in FY2025 (Dec). Vera Therapeutics stock rose 19.7% that year.

Pay$100 in the stock at the end of FY22 → $262
Pay is from the Summary Compensation Table of each Vera Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Caribou BiosciencesPublic company · 2 yr
    • Director2024 – Present · 2 yrNo stock prices for these years
  2. Vera TherapeuticsPublic company · 3 yr
    • Chief Operating Officer2023 – Present · 3 yrStock in role +61%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?